Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Wietek, Stefan
62  Ergebnisse:
Personensuche X
?
1

Sustained functional benefits after a single set of injecti..:

Patel, Atul T. ; Lew, Mark F. ; Dashtipour, Khashayar...
PLOS ONE.  16 (2021)  2 - p. e0245827 , 2021
Link: https://doi.org/10.1371/..
 
?
2

Correction: Sustained functional benefits after a single se..:

Patel, Atul T. ; Lew, Mark F. ; Dashtipour, Khashayar...
PLOS ONE.  16 (2021)  4 - p. e0250475 , 2021
Link: https://doi.org/10.1371/..
 
?
3

AbobotulinumtoxinA provides flexibility for the treatment o..:

Lew, Mark F. ; Hauser, Robert A. ; Isaacson, Stuart H....
Clinical Parkinsonism & Related Disorders.  5 (2021)  - p. 100115 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Efficacy and Safety of AbobotulinumtoxinA in Pediatric Lowe..:

Gormley, Mark ; Dabrowski, Edward ; Tilton, Ann...
Neurology.  96 (2021)  15_supplement - p. , 2021
Link: https://doi.org/10.1212/..
 
?
5

Development of the Hygiene Extension Limb Position Pain (HE..:

Patel, Atul ; Wietek, Stefan ; Dabrowski, Edward
Toxicon.  190 (2021)  - p. S57 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Efficacy and safety of abobotulinumtoxinA in pediatric lowe..:

Gormley, Mark ; Dabrowski, Edward ; Tilton, Ann...
Toxicon.  190 (2021)  - p. S28 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Efficacy and Safety of AbobotulinumtoxinA in Pediatric Lowe..:

Gormley, Mark ; Dabrowski, Edward ; Delgado, Mauricio...
Neurology.  94 (2020)  15_supplement - p. , 2020
Link: https://doi.org/10.1212/..
 
?
8

AbobotulinumtoxinA using 2-mL dilution (500 U/2-mL) maintai..:

Dashtipour, Khashayar ; Wietek, Stefan ; Rubin, Bruce...
Journal of Clinical Movement Disorders.  7 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
9

Octagam®for Chronic Inflammatory Demyelinating Polyneuropat..:

Wietek, Stefan
Neurodegenerative Disease Management.  8 (2018)  4 - p. 227-231 , 2018
Link: https://doi.org/10.2217/..
 
?
10

Tolerability and safety of the intravenous immunoglobulin o..:

Wietek, Stefan ; Svorc, Daniel ; Debes, Anette.
Hematology.  23 (2017)  4 - p. 242-247 , 2017
Link: https://doi.org/10.1080/..
 
?
11

Tolerability and safety of Octagam® (IVIG): a post-authoriz..:

Frenzel, Wolfgang ; Wietek, Stefan ; Svae, Tor-Einar..
Int. Journal of Clinical Pharmacology and Therapeutics.  54 (2016)  11 - p. 847-855 , 2016
Link: https://doi.org/10.5414/..
 
?
12

Predicting therapeutic efficacy of intravenous immunoglobul..:

Berger, Thomas ; Jacobi, Christian ; Haas, Judith...
Journal of Neuroimmunology.  277 (2014)  1-2 - p. 145-152 , 2014
Link: https://doi.org/10.1016/..
 
?
13

P4‐362: Brain glucose metabolism in patients with mild to m..:

Rominger, Axel ; Foerster, Stefan ; Zach, Christian...
Alzheimer's & Dementia.  7 (2011)  4S_Part_24 - p. , 2011
Link: https://doi.org/10.1016/..
 
?
14

P4‐411: A randomized, double‐blind, placebo‐controlled dose..:

Dodel, Richard ; Rominger, Axel ; Blennow, Kaj...
Alzheimer's & Dementia.  7 (2011)  4S_Part_25 - p. , 2011
Link: https://doi.org/10.1016/..
 
?
15

P3‐283: Randomized double‐blind placebo‐controlled dose‐fin..:

Farlow, Martin R. ; Jessen, Frank ; Wietek, Stefan...
Alzheimer's & Dementia.  6 (2010)  4S_Part_17 - p. , 2010
Link: https://doi.org/10.1016/..
 
1-15